The global osteoarthritis therapeutics market is expected to grow by USD 2.99 billion as per Technavio. This marks a significant market slowdown compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. However, healthy growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of almost 9%.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200508005287/en/
Technavio has announced the latest market research report titled Global Osteoarthritis Therapeutics Market 2020-2024 (Graphic: Business Wire)
Request challenges and opportunities that influence COVID-19 pandemic Request free sample pages of the osteoarthritis therapeutics market
Read the 120-page report with TOC on "Osteoarthritis Therapeutics Market Analysis Report by Product (Analgesics and NSAIDs, Corticosteroids, Viscosupplements, and Others) and Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts, 2020-2024".
https://www.technavio.com/report/global-osteoarthritis-therapeutics-market-industry-analysis
The market is driven by the increasing incidence of osteoarthritis. In addition, the availability of guidelines for disease management is anticipated to boost the growth of the osteoarthritis therapeutics market.
The rising incidence of risk factors such as obesity and aging is increasing the prevalence of osteoarthritis across the world. The high body weight of obese people makes them more susceptible to osteoarthritis. Similarly, in the geriatric population, the reduced muscle mass and an increase in fat mass leads to joint loading, which can result in the progression of osteoarthritis. These factors are increasing the prevalence of osteoarthritis, which is fueling the growth of the global osteoarthritis therapeutics market.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Osteoarthritis Therapeutics Companies:
Abbott Laboratories
Abbott Laboratories operates its business through segments such as Established Pharmaceuticals Products, Nutritional Products, Diagnostic Products, and Medical Devices. The company offers BRUFEN RETARD. It is an NSAID indicated for its analgesic and anti-inflammatory effects in the treatment of osteoarthritis.
Anika Therapeutics Inc.
Anika Therapeutics Inc. operates its business through the Unified business segment. The company offers MONOVISC. It is a single injection viscosupplement composed of cross-linked sodium hyaluronate in phosphate buffered saline solution used to treat the joint pain associated with osteoarthritis.
Bayer AG
Bayer AG operates its business through segments such as Pharmaceuticals, Crop Science, and Consumer Health. The company offers Aleve. It is an NSAID used to reduce pain in patients with osteoarthritis.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. operates its business through segments such as Pharmaceuticals and Diagnostics. The company offers Actemra. It is an anti-IL-6 receptor biologic indicated for the treatment of rheumatoid arthritis and hand osteoarthritis.
GlaxoSmithKline Plc
GlaxoSmithKline Plc operates its business through segments such as Pharmaceuticals, Consumer Healthcare, and Vaccines. The company offers Voltaren. It is an NSAID used to reduce pain in patients with osteoarthritis.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Osteoarthritis Therapeutics Market Product Outlook (Revenue, USD Billion, 2020-2024)
- Analgesics and NSAIDs
- Corticosteroids
- Viscosupplements
- Others
Osteoarthritis Therapeutics Market Regional Outlook (Revenue, USD Billion, 2020-2024)
- North America
- Europe
- Asia
- ROW
Technavio's sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Healthcare Include:
Global Knee Replacement Market Global knee replacement market by geography (Asia, Europe, North America, and ROW) and product (TKR, RKR, and PKR).
Global Digit Joint Implants Market Global digit joint implants market by product (MCP and PIP joint implants, trapeziometacarpal joint implants, toe implants, and others), type (foot and hand), and geography (Asia, Europe, North America, and ROW).
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200508005287/en/
Contacts:
Technavio Research
Jesse Maida
Media Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
